PDCD1 and cancer: The previous study using The Cancer Genome Atlas and the Cancer Cell Line Encyclopedia RNA sequencing data from anti-PD1-treated patients with melanoma demonstrated that the low TNFSF4 mRNA expression group was associated with worse prognosis and showed a worse outcome after anti-PD1 treatment [28].